Cataract
Conditions
Brief summary
The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.
Interventions
DRUGKetorolac, Nepafenac
Sponsors
Innovative Medical
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* · Male or female \> 18 years of age scheduled to undergo cataract surgery * Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams) * Ability to provide informed consent and likely to complete all study visits
Exclusion criteria
* · Known contraindication to any study medication or any of their components * Uncontrolled systemic disease * Required use of ocular medications other than the study medications during the study * Abnormal pre-operative OCTs if obtainable * Diabetic patients * Use of oral NSAIDS * Patients with ocular disease (macula degeneration, glaucoma, corneal disease) which reduces the potential visual rehabilitation (patients will ocular disease that will no preclude achievement of a 20/20 visual outcome may be included)..
Countries
United States
Outcome results
None listed